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The porphyrin macromolecule has provided mankind with many 
important breakthroughs ranging from photometric and electrochemical 
analysis to photosynthesis, oxygen activation, solar cell, molecular recognition 
and photodynamic therapy. With such wealth information embedded in the 
porphyrin, a researcher just has to turn a more inquisitive mind into probing 
the porphyrin system for possibly solving some of the most serious problems 
facing mankind. Indeed, the aim of this thesis is to explore a series of 
porphyrins or metalloporphyrins for the purpose of inspiring new antibiotics. 
This is achievable due to the porphyrin’s stable configuration which allows for 
modification by electrophilic substitution reactions in the meso-positions 5, 10, 
15, 20 and the β-pyrrole positions 2, 3, 7, 8, 12, 13, 17, 18, therefore enabling 
the synthesis of a range of structural and electronic differentiated compounds 
In view of our interest, a series of electronic differentiated porphyrins and 
metalloporphyrins were designed and synthesized in our research. They were 
designed according to the increased in electron donating capabilities 
associated with different functional groups (Cl, H, methyl, and ethyl) in the 
4-phenyl position as well as substituted bromine in the 10 and 20 positions in 
the porphyrin macrocycle. The manganese, cobalt and zinc were selected as 
the central metals of metalloporphyrins. All the synthesized porphyrins and 
metalloporphyrins were tested firstly using a technique known as the 
minimum inhibition concentration test in order to determine their 
IV 
 
anti-microbial property and, subsequently their cytotoxicity evaluated towards 
healthy mammalian cells by determination of hemolysis of rabbit red blood 
cells as well as MTT assay of human fibroblast cells. The preliminary results 
obtained to-date suggests potential of the synthesized porphyrins as a new 
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Chapter 1 Introduction to porphyrin and its derivatives 
 
1.1 General introduction to porphyrin and its derivation 
Porphyrins are a large group of intensely colored heterocyclic 
macrocyclic organic compounds existing universally in biological distribution 
around the earth, and consist of four modified pyrrole ring subunits 
interconnected at their α carbon atoms linked by methine bridge (=CH-) as 
part of a substituted aromatic macrocyclic ring.1 The word porphyrin 
originates from porphura2 as a Greek word depicting purple which today we 
know arises from the highly conjugated 18-election π periphery of the 
aromatic macrocycle.3 Numerous classical natural porphyrin compounds exist 
in the environment; such as the iron-containing porphyrin found as heme,4 the 
magnesium-containing porphyrin found in chlorophyll,5 as well as the cobalt 
containing vitamin B12 porphyrin complex.6 (Figure 1.1) During the past 
century, porphyrins and their derivatives have been intensively studied due to 
their central roles in life sustaining metabolic functions ranging from 
photosynthesis, oxygen activation, electron transfer to catalysis. Recently, 
porphyrins and their derivatives are increasingly sought after in new areas 
such as solar cell7, photodynamic therapy and charge transfer properties. It is 
reasonable to believe that in the near foreseeable future, the porphyrins and 
their derivatives will continue to attract attention from multi-disciplinary 
researchers across fields (materials,8 engineering,9 optics,10 chemistry11 and 
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pharmaceuticals12) due to its versatile and practical characteristics, which will 
lead to progressive and comprehensive benefits for the human society.13 
 
  
Figure 1.1 (a) haem, (b) chlorophyll, (c) Vitamin B12. 
 
1.2 Structure and electronic bands 
The basic structure of porphyrin is depicted in Figure 1.2 (a) and 
contains 22π electrons, therefore by Hückel’s rule, it is aromatic (4n+2 
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delocalized π electrons), but only 18 of them are delocalized.14 (Figure 1.2 (b)) 
Thus prophyrin marcocycle is a highly conjugated system and consequently 
porphyrins and their derivatives have very intense absorption bands in the 
visible region which explains their deep purple coloration. This unique feature 
renders a stable configuration which allows for modification of the macrocycle 
typically achieved by electrophilic substitution reactions. As seen in Figure 
1.2 (a), positions 5, 10, 15 and 20 are called meso - while positions 2, 3, 7, 8, 
12, 13, 17 and 18 are called β-pyrrole positions.15, 16 Modifications usually 
take place among these sites, which leads to the change of the electronic, 
physical and chemical properties of the desired porphyrins. 
 
Figure 1.2 The basic porphyrin structure and 18e- structure of porphyrin 
Porphyrins have a distinctive electronic absorption which can be 
distinguished from other molecules. An intense absorption in the region of 
380–450 nm with molar extinction coefficients of 105 M-1cm-1 is known as the 
Soret or B-band while a set of weaker absorption in the region of 500–750 nm 
with molar extinction coefficients of up to 104 M-1cm-1 is assigned as the Q 
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bands.17 These wavelength and intensity of these adsorption bands can vary as 
functions of pH, temperature, solvent and central metal and hence permits 
useful information about kinetic and photophysical properties of differentiated 
porphyrins for various applications. Hence, free-base porphyrins show four 
Q-bands (IV, III, II and I) with different relative intensities, depending on the 
functionalization both at the β-pyrrole positions and the meso- carbons. 
Metallation of the macrocycle produces a more symmetrical ring, thus 
simplifying the Q-bands from four to two bands. 
Gouterman18 has done groundbreaking work on the understanding of the 
porphyrin absorption spectrum. The origins of the porphyrin electronic 
spectrum are dictated by its conjugation pathway and symmetry, and have 
been successfully explained using the four orbital model. According to this 
theory, the absorption bands in porphyrin systems arise from transitions 
between two HOMOs and two LUMOs orbital (two highest occupied π 
orbitals and two lowest unoccupied π* orbitals), factors ranging from the 
metal center to the substituents on the ring can affect the relative energies of 
these transitions. In the case of a free base porphyrin, the HOMOs are 
designated as the a1u and a2u orbitals, while the LUMOs are determined to be a 
set of eg orbitals. (Figure 1.3) Electron transitions between these orbitals led 
to two excited states, one is an energy state with greater oscillator strength 
known as the Soret band (S0→S2, 380-450 nm), and the other one is an 
energy state with less oscillator strength that gives rise to the Q bands (S0→S1, 
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500-750 nm) as discussed earlier. Because of the x and y polarization of the 
free base porphyrin, the HOMO and HOMO-1 energy levels are not 
degenerate, therefore splitting the Q band into four.19 These special 
spectroscopic features of porphyrins hence provide an easy and precise 
method to monitor the guest-binding process by UV-visible spectroscopy.  
It should be noted that variations of the peripheral substituents on the 
porphyrin ring usually only results in minor changes to the absorption features 
while metal insertion leads to significant change to the absorption spectrum. 
The reason is that when a metal is coordinated into porphyrin’s macrocycle, 
the symmetry is changed from D2h to a 4-fold symmetry (D4h). The change of 
symmetry induces an increase in the LUMO and LUMO+1 molecular orbitals 
non-degeneracy which simplifies the Q bands pattern. This can be explained in 
terms of the x-polarization of excited states originating from a’1u→e’gy and 
a’2u→e’gx transitions, while y-polarized transitions are due to a’1u→e’gx and 
a’2u→e’gy orbitals. The x and y-polarized excited states are further mixed and 
split in energy by configuration interaction into two pairs of the degenerate 1Eu 
(Qx and Qy) and 2Eu (Bx and By or Soret band) transitions.20 
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Figure 1.3 Simplified Gouterman’s four-orbital model for D4h symmetry 
transition-metal porphyrins (top) and D2h symmetry metal-free porphyrins 
(bottom). 
 
1.3 Properties of porphyrin 
Both porphyrins and metalloporphyrins exhibit intense absorption due to 
the π-conjugation, and demonstrate high melting point due to their thermal 
stability. Another defining characteristic of porphyrins are their unique 
fluorescence and phosphorescence for metalloporphyrins. Porphyrins can be 
synthesized as water-soluble species, organic solvent soluble species or high 
molecular weight polymers species totally insoluble in any solvents, 
depending on the desired applications. Water-soluble porphyrins, for example, 
5,10,15,20-Tetrakis(4-sulfophenyl)-21H,23H-porphine (Figure 1.4 (a)) can be 
dissolved in not only water but also N,N-dimethylformamide. Water-insoluble 
porphyrins, such as 5,10,15,20-Tetrakis(4-chlorophenyl)-21H,23H-porphine 
(Figure 1.4 (b)) usually can be dissolved in dichloromethane, chloroform, 
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N,N-dimethylformamide, tetrahydrofuran and dimethylsulfoxide.  
 
Figure 1.4 Examples of porphyrins, (a) 5,10,15,20-Tetrakis(4-sulfophenyl)- 
21H,23H-porphine, (b) 5,10,15,20-Tetrakis(4-chlorophenyl)-21H,23H- 
porphine. 
The distance between the cavity center of porphyrin and the 4 nitrogen 
atoms is 0.204 nm, which is consistent with the sum of covalent radius of first 
transition metal atoms and nitrogen atom, therefore allowing porphyrin 
compounds and transition metal ions to form stable 1:1 metal complexes. In 
addition, because of its aromaticity,21 modification of the macrocycle can be 
typically achieved by electrophilic substitution reactions in the meso- carbon 
atoms (positions 5, 10, 15, 20) and the β-carbon atoms (positions 2, 3, 7, 8, 12, 
13, 17, 18).22 (Figure 1.1) For example, chlorination and bromination can take 
place quite readily. The coupling reaction between the aromatic bromine and 
boronic substrates is most readily catalyzed by compounds of palladium and 
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other transition metals. Using the Suzuki coupling reaction23, the brominated 
porphyrins can be utilized in Heck24, Stille25, Sonogashira26, Negishi27 
coupling reactions to create bigger building blocks. Using these methods, 
C-heteroatom bonds (O, N, S, P, B) are achievable. In addition,  nucleophilic 
substitution enables the replacement of the bromine in the macrocycle of 
porphyrin by a hydroxyl group28 or a cyano group.29，30 
 
1.4 Synthesis methods and characterization 
1.4.1 Adler-Longo synthetic method 
The classical route to obtain porphyrins was based on the work by 
Rothemund.31 It was a one-step reaction between benzaldehyde and pyrrole 
using pyridine as the solvent at 150℃ resulted in tetraphenylporphyrin but 
yields were low. In addition, only a few aldehydes are suitable because of the 
harsh conditions. Rothemund’s accomplishment was superseded by more 
modern synthesis designed by Adler and Longo.32 An acid catalyzed pyrrole 
and aldehyde condensation in the presence of air subsequently expanded the 
scope of aldehyde that could be used and resulted in improved porphyrin 
yields. Formic acid, acetic acid and propionic acid are typical reaction solvents. 
(Scheme 1.1) Adler and Longo discovered that pyrrole and benzaldehyde in 
the presence of an acid were dehydrated to form chain compound 
porphyrinogen, and when the number of polymerized units is 4, the chain 
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compound can be oxidized by oxygen to form tetraphenylporphyrin. Although 
more than 70 kinds of aldehydes and pyrrole have been used in this method, it 
is not effective for some aldehydes with sensitive groups or strong electron 
withdrawing groups.  
 
Scheme 1.1 Classical synthetic route of porphyrins developed by Adler and 
Longo. 
 
1.4.2 Lindsey synthetic method 
The latest and most benign method of porphyrin synthesis was developed 
by Lindsey, it is a 2 steps synthetic route; firstly the condensation of aldehydes 
and pyrrole followed by oxidation to obtain the desired porphyrin 
macrocycles.33 (Scheme 1.2) This reaction just needs mild condition and will 
not form tar-like by-product with high yield. It is a preferred method for the 
synthesis of porphyrins with sensitive groups. But the reaction process 
requires dry and oxygen-free operation condition and should be carried out in 
10 
 
a very diluted solution, which is not suitable for large scale production of 
porphyrins.  
 
Scheme 1.2 Lindsey 2-step, one-flask room-temperature synthetic route of 
porphyrins. 
If an appropriate amount of ethanol was added as a co-catalyst of boron 
trifluoride in the reaction system, this method can be used to synthesize 
ortho-substituted tetra-aryl porphyrins typically challenging under ordinary 
conditions because of the huge steric hindrance, such as 







Figure 1.5 Structure of 5,10,15,20-Tetrakis(2,4,6-trimethylphenyl)-21H,23H- 
porphine 
In this light, the approach we sought to undertake in the synthesis of 
porphyrins will be modified from Lindsey’s procedures. 
 
1.4.3 Microwave irradiation synthetic method 
In 1986, Gedye35 found that microwave can accelerate the reaction rate 
much faster than conventional heating methods. Soon after, green chemistry 
synthetic method are developed using microwave irradiation of reactants 
adsorbed on acidic silica gel36 or at high temperature in the gas phase.37 For 
example, Petit36 designed an experiment that adsorbed benzaldehyde and 
pyrrole on a solid support under microwave irradiation for 10 minutes and 
continuous shaking before simple elution on silica and crystallization yielded 
the pure product. The experiment result showed that silica gel (200-500 μm) 
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was the best support for the synthesis of porphyrin under microwave 
irradiation. Talc (hydrous magnesium silicate) as catalyst was also effective. 
Although the overall yield was relatively low, it is a good alternative method 
to synthesize small quantities of pure porphyrin quickly considering the rapid 
procedure, easy operation and purification steps.  
 
1.5 Applications of porphyrin and its derivatives 
Several applications for porphyrins are discussed below, but the list is 
non-exhaustive due to the increased interests of porphyrin research towards 
prospective new areas. Applications listed below are just some general 
description of the promising areas of research in the utilization of porphyrin 
and its derivatives. 
 
1.5.1 Additive in novel material synthesis 
Porphyrins are widely used in the manufacture of optoelectronic 
materials, such as magnetic materials, nonlinear optical materials production.38, 
39, 40, 41 Meanwhile porphyrins can form liquid crystal with many metals 
including Co, Zn and Cu, for example metallic complexes of 
5,10,15,20-Tetrakis(4-hydroxyphenyl)-21H,23H-porphines.42 (Figure 1.6 (a)) 
Porphyrins, especially after coordinating with transition metals has strong light 
absorbing property, they can emit strong phosphorescence that can be 
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quenched by oxygen.43 High-efficiency (≥90%) energy transfer from both 
singlet and triplet states was reported in a host material doped with the 
phosphorescent dye 2,3,7,8,12,13,17,18-octaethyl-21H,23H-porphine 
platinum(II) (PtOEP).44 (Figure 1.6 (b)) The doped electroluminescent 
devices generated saturated red emission with peak external and internal 
quantum efficiencies of 4% and 23%, respectively. The luminescent 
efficiencies attainable with phosphorescent dyes may lead to new applications 
for organic materials. In nonlinear optics field, porphyrins also attract 
increasing interest due to their excellent properties in optical limiter, laser 
modulation, and optical bi-stability for the application of phase conjugate and 
optical switch materials. 
 
Figure 1.6 Structure of (a) 5,10,15,20-Tetrakis(4-hydroxyphenyl)-21H,23H- 
porphines and (b) 2,3,7,8,12,13,17,18-octaethyl-21H,23H-porphine platinum 
(II) (PtOEP ) 
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1.5.2 Energy conversion -- Solar cell 
Due to war, famine, disease and overpopulation, humanity faces 
unprecedented energy generation, water pollution and resources problems.  
Fortunately, nature has the answer with regards to energy shortages issues as 
solar energy is calculated to provide the biosphere with about 1024 J per year, 
when 1021 J is enough to satisfy human’s annual energy consumption needs.45 
Compared with traditional semiconducting solar cell, the organic 
molecules or polymers provide a cheaper route toward solar energy conversion. 
This is partly because organic molecules or polymers can be easily and 
cheaply deposited or spin-coated on conducting anode substrates.46  
Figure 1.7 shows a hexaphenylbenzene structure that contains five 
lightharvesting 9,10-bis(phenylethynyl)-anthracene (BPEA) groups and a Zn 
porphyrin.47 The reaction center comprises of the Zn porphyrin as the primary 
electron donor and a C60 moiety as the acceptor. In this structure, five BPEA 
units played the role of antennas to provide substantial absorption cross 
section in the blue-green region of the spectrum. In terms of capturing of a 
photon, excitation energy is transferred efficiently among the BPEA units 
(indicated by the yellow shading) until it is trapped to generate the lower 
energy excited state of the Zn-porphyrin (indicated by the green arrows). Once 
excited, the use of covalent linked Zn-porphyrin in conjunction with C60 
fullerene allows long-lived charge separated state PZn•+ -C60•− (red arrow). 
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Both energy and electron transfer processes depend upon thermodynamic and 
electronic coupling parameters between the appropriate chromophores.47 The 
principle of energy transfer in this example was developed initially by Förster 
and Dexter, as models for electronic and thermodynamic coupling to give a 
high quantum yield of energy transfer.48 In addition, electrophoretic deposition 
of the porphyrin and fullerene dyads allows for nanostructure morphology 
tuning on electrode surface towards optimal device performance during the 
organic solar cell fabrication process.  
Figure 1.7 An example of synthetic antenna-reaction center complex  
 
1.5.3 Catalysis -- Cobalt porphyrins in living radical polymerization 
Metalloporphyrins are excellent catalysts for many reactions due to their 
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unique stereo-planar configuration that allows for a variety of stable 5 
coordinated metal species to enter its cavity while allowing substrate 
interaction in an axial fashion at the vacant 6th coordination site. 
Living radical polymerization (LRP) has become a powerful tool in 
constructing polymeric materials with predetermined molecular weight and 
narrow polydispersity for a substantial range of monomers.49 The major 
research theme of LRP now is to develop a catalyst to enlarge the scope of 
monomers suiting for LRP.50 A cobalt porphyrin complex (TMP-OH)Co 
(Figure 1.8) recently was synthesized to catalyse LRP of organic and water 
soluble acrylates and acrylamides. The capability of this cobalt complex to 
mediate LRP in both polar and non-polar media permits the direct synthesis of 
useful and previously difficult to prepare functional block copolymers.51 
Figure 1.8 Cobalt porphyrin complexes. 
 
1.5.4 Photodynamic therapy 
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Photodynamic therapy (PDT) is a photosensitization based cancer therapy 
that relies on the selective introduction of photosensitizers into cancer cells to 
undergo apoptosis by singlet oxygen generated by light irradiation.52 
Photosensitizers have a stable electronic configuration, which is in a singlet 
state in their lowest or ground energy level named 0PS.53 This means there is 
no unpaired electron spin54. When the photosensitizer absorbs a photon of 
light of specific wavelength, it is excited to be an excited state named 0PS* 
which is shortly lived with a half-life between 10-6 and 10-9 s.53 The 
photosensitizer may return back to the ground state by emitting a photon as 
light energy (fluorescence), or just wastes its energy by internal conversion as 
heat. Alternatively, via intersystem crossing involving a change of an electron 
spin, the molecule can convert to its triplet state 2PS*.55 The triplet state has 
lower energy than the singlet state but has longer lifetime. According to the 
mechanism shown in Figure 1.9, type I reaction produces free radicals, 
meanwhile, type II reaction requiring an energy transfer from triplet state to 
singlet state leads to the production of 1O2. All these reactive species can 
induce irreversible targeted cancer cell damage but do not damage other 
neighboring healthy cells due to their limited diffusion in water environment.56 
And the photosensitizers return to their ground state to repeat the process of 
energy transfer. More details about the photodynamic therapy for bacteria are 
in Chapter 3.1.2.1. 
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Figure 1.9 The mechanism of photodynamic therapy. Numbers in superscripts 
denote the number of unpaired electron spins in each molecule.57  
 
1.6 Research proposal 
1.6.1 Drug-resistance 
Drug-resistance is an evolution of microorganisms’ sensitivity to a 
specific drug. Many strains may stem from the same original microorganism, 
but their sensitivity to the drug is different due to the possible gene mutation in 
the multiplicative process. Unless the specified antibiotic drug can prevent 
cellular reproduction or exterminate every single strain of the microorganism, 
surviving strains of microorganisms can evolve to entail the drug-resistant 
traits (drug-resistance gene) to their progenies, therefore, resulting in 
development of resistance to the prescribed drug.  
One of the ways how drug-resistance can forms part of a bacteria defence 
against foreign threats is the ability to mutate segments of its genetic 
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RNAs/DNAs or proteins that is being targeted by a specific kind of antibiotic. 
These incredible microorganisms can not only change the proteins or RNAs or 
DNAs targeted by antibiotics, but also break down the antibiotic to neutralize 
their toxicity.58 Some examples of target-altering microorganisms are 
vancomycin-resistant Enterococci and Staphylococcus Aureus, while 
aminoglycoside-resistant Acinetobacter Baumannii and Pseudomonas 
Aeruginosa adapt an antibiotic neutralizing strategy. It should be noted that 
drug-resistance is generated not only in medical settings but also possibly in 
daily life as well. Some daily sanitation and hygiene management include 
tooth-brushing, hand-washing, the use of antibacterial shampoo, soaps and 
deodorants etc. can also increase the drug-resistance of some 
microorganisms.59 Without new and alternative strategies, the existing 
strategies for developing antibiotics along similar chemical structures appears 
destine to fail. This could unleash one of the most serious public health threats 
facing the human population in the future since the seemingly incurable days 
of the black plague.60 
 
1.6.2 Research proposal 
From the above discussion, it is obvious that porphyrins and its 
derivatives have tremendous functions and properties due to their stable 
configuration which allows for modification of macrocycle. Recently, a series 
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of pharmacology verification of porphyrins in different biological applications, 
demonstrated very low toxicity to healthy mammalian cells. 52, 53, 56, 57 This 
could be a way forward in developing low toxicity and effective drugs that 
targets drug resistance bacteria, as well as minimize the sides effects caused by 
common antibiotics. 
Hence, in this project, a series of porphyrin and their corresponding metal 
complexes will be synthesized through the fundamental synthetic route. Their 
structures will be characterized and confirmed by NMR, ESI and UV-Vis. 
Subsequently, all the products will be tested by a series of biological assays on 
cell lines and bacteria culture in order to determine their anti-bacterial 
properties and relative toxicity to healthy mammalian cells. The bacterial 
assays include the minimum inhibition concentration (MIC) (µg/mL) against 
Gram-negative bacteria (E. coli) and Gram-positive bacteria (S. aureus), 
(Chapter 3.1.1 presents the difference of gram-positive and gram-negative 
bacteria) which will be compared with available commercial antibiotics (e.g. 
the MIC of Vancomycin or polymycin B is around 1 µg/ml, Chapter 3.1.2) to 
prove their effectiveness. Toxicity to healthy mammalian cells will be carried 
out by hemolysis61 of rabbit blood and MTT assay62. (The MTT assay is a 
colorimetric assay for assessing cell viability. NAD(P)H-dependent cellular 
oxidoreductase enzymes existing in viable cells can reduce the tetrazolium dye 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide to its 




Based on the assay data, compounds with better anti-microbial properties 
will be selected, and the functional groups will be further modified to improve 
their anti-microbial performance. Our aim is to develop one or more porphyrin 
based complexes that are effective toward wild strain, antibiotic-resistant 
gram-positive and gram-negative bacteria. In general, extensive eradication of 
pathogens should be achieved rapidly with low toxicity to cells, such as 
keratinocytes. Finally, we hope to elucidate the anti-microbial mechanism as a 




Chapter 2 Synthesis and characterization of porphyrins and their metal 
complexes 
 
2.1 Synthesis methods 
The general synthesis procedure of the metalloporphyrins adapted from 
Lindsey’s method33 typically involves 3 synthetic steps. Firstly the pyrrole and 
paraformaldehyde are catalyzed by trifluoroacetic acid to form 
dipyrromethane. Secondly, the condensation of aldehyde and dipyrromethane 
is carried out followed by oxidation by a mild oxidant such as p-choranil to 
generate the free base porphyrin. (Scheme 2.1) Thirdly, the desired metal ion 
is inserted into the porphyrin cavity in a form of acetate or chlorate salt to 
complete the synthesis. (Scheme 2.2) Different metals are inserted into the 
porphyrin cavity to determine their effects on the various bacteria colony 
assays including MIC, hemolysis61 and MTT62. In addition, we also studied 
structural effect by modifying the phenyl group at the 5 and 15 positions as 
well as the electrophilic substitution of bromine on the 10, 20 positions. 
(Scheme 2.3) It is expected that the electron donating\withdrawing properties 
of porphyrin substituents may also influence the bioassay (MIC, MTT and 













3. Purify by column chromatography









Scheme 2.2 Synthetic methodology of the metal porphyrins. 
 
Scheme 2.3 Synthetic methodology of bromo-substituted porphyrins. 
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2.2 Experimental section 
2.2.1 Synthesis of free base porphyrins 
Synthesis of dipyrromethane63 
 
Paraformaldehyde (1.00 g, 33.33 mmol) and indium trichloride (0.65 g, 
2.94 mmol) was dissolved in pyrrole (195.00 g, 2.91 mol) heated at 55℃ for 
12 hours under N2. The excess pyrrole was distilled out and gathered in the 
cool trap (acetone and dry ice) for recycle use. The remaining mixture eluted 
with hexane/ethyl acetate/triethylamine (80/20/1) mixed solvent on a silica gel 
column to remove the side products. The eluent was dried through rotary 
evaporator and vacuum pump, then the dipyrromethane was gotten as a white 
solid, Rf = 0.31. Yield: 3.30 g, 68.3 %. 1H NMR (500MHz, CDCl3) δ: 7.81(br, 
s, 2H), 6.64 (m, 2H), 6.15 (q, J = 2.9 Hz, 2H), 6.03 (m, 2H), 3.96 (s, 




Synthesis of 5,15-bis(4-methylphenyl)-21H,23H-Porphine (1.MePor)64 
 
Dipyrromethane (1.00 g, 6.84 mmol) and 4-methylbenzaldehyde (0.82 g, 
6.84 mmol) were dissolved in CH2Cl2 (500 ml). The mixture was stirred 
rapidly before trifluoroacetic acid (0.15 g, 1.31 mmol) was added to the 
solution which then gradually turned red. After 12 hours of stirring, 
p-chloranil (3.36 g, 13.68 mmol) was added to the solution and stirring 
continues for 3 hours. Then the mixture was purified by silica gel 
chromatography using CH2Cl2 as the eluent to yield a purple solid. Rf = 0.75. 
Yield: 0.40 g, 23.8 %. 1H NMR (500MHz, CDCl3) δ: 10.31 (s, 2H, meso-H), 
9.39 (d, 4H, pyrrole), 9.11 (d, 4H, pyrrole), 8.16 (d, 4H, phenyl), 7.62 (d, 4H, 
phenyl), 2.74 (s, 6H, methyl), -3.10 (s, 2H, NH). ESI-MS (m/z, %): [M+H]+ 




Synthesis of 5,15-bis(4-chlorophenyl)-21H,23H-Porphine (4.ClPor)65 
 
Dipyrromethane (1.00 g, 6.84 mmol) and 4-chlorobenzaldehyde (0.96 g, 
6.84 mmol) were dissolved in CH2Cl2 (500 ml). The mixture was stirred 
rapidly before trifluoroacetic acid (0.15 g, 1.31 mmol) was added to the 
solution which then gradually turned red. After 12 hours of stirring, 
p-chloranil (3.36 g, 13.68 mmol) was added to the solution and stirring 
continues for 3 hours. Then the mixture was purified by silica gel 
chromatography using CH2Cl2 as the eluent to yield a purple solid. Rf = 0.55. 
Yield: 0.10 g, 5.5 %. 1H NMR (300MHz, THF-d8) δ: 10.48 (s, 2H, meso-H), 
9.53 (d, 4H, pyrrole), 9.10 (d, 4H, pyrrole), 8.31 (d, 4H, phenyl), 7.90 (d, 4H, 




Synthesis of 5,15-bis(phenyl)-21H,23H-Porphine (5.Por)64 
 
Dipyrromethane (1.00 g, 6.84 mmol) and benzaldehyde (0.73 g, 6.84 
mmol) were dissolved in CH2Cl2 (500 ml). The mixture was stirred rapidly 
before trifluoroacetic acid (0.15 g, 1.31 mmol) was added to the solution 
which then gradually turned red. After 12 hours of stirring, p-chloranil (3.36 g, 
13.68 mmol) was added to the solution and stirring continues for 3 hours. 
Then the mixture was purified by silica gel chromatography using CH2Cl2 as 
the eluent to yield a purple solid. Rf = 0.67. Yield: 0.62 g, 39.2 %. 1H NMR 
(500MHz, CDCl3) δ: 10.32 (s, 2H, meso-H), 9.40 (d, 4H, pyrrole), 9.09 (d, 4H, 
pyrrole), 8.29-8.27 (m, 4H, phenyl), 7.81 (t, 6H, phenyl), -3.11 (s, 2H, NH). 




Synthesis of 5,15-bis(4-ethylphenyl)-21H,23H-Porphine (14.EtPor)66 
 
Dipyrromethane (1.00 g, 6.84 mmol) and 4-ethylbenzaldehyde (0.92 g, 
6.84 mmol) were dissolved in CH2Cl2 (500 ml). The mixture was stirred 
rapidly before trifluoroacetic acid (0.15 g, 1.31 mmol) was added to the 
solution which then gradually turned red. After 12 hours of stirring, 
p-chloranil (3.36 g, 13.68 mmol) was added to the solution and stirring 
continues for 3 hours. Then the mixture was purified by silica gel 
chromatography using CH2Cl2 as the eluent to yield a purple solid. Rf = 0.71. 
Yield: 0.46 g, 25.9 %. 1H NMR (300MHz, THF-d8) δ: 10.38 (s, 2H, meso-H), 
9.44 (d, 4H, pyrrole), 9.06 (d, 4H, pyrrole), 8.19 (d, 4H, phenyl), 7.68 (d, 4H, 
phenyl), 3.08-3.00 (m, 4H, methylene), 1.56 (t, 6H, methyl), -3.01 (s, 2H, NH). 




2.2.2 Synthesis of bromine substituted prophyrins 
Synthesis of 10-bromo-5,15-bis(4-methylphenyl)-21H,23H-Porphine 
(12.MonoBr-MePor)63 
 
A CHCl3 solution (500 ml) of 
5,15-bis(4-methylphenyl)-21H,23H-Porphine (1.00 g, 2.04 mmol) was added 
pyridine (1 ml) and N-bromobutanimide (0.36 g, 2.04 mmol) at 0℃. After 
stirring at the same temperature for 1 hour, the solution was concentrated in 
vacuo. Then the product was purified by column chromatography on silica gel 
(hexane/DCM 10:1) to yield a purple solid. Rf = 0.34. Yield: 0.29 g, 25.0 %. 
1H NMR (300MHz, CDCl3) δ: 10.17 (s, 1H, meso-H), 9.73 (d, 2H, pyrrole), 
9.28 (d, 2H, pyrrole), 8.99-8.97 (m, 4H, pyrrole), 8.10 (d, 4H, phenyl), 7.60 (d, 
4H, phenyl), 2.73 (s, 6H, methyl), -2.99 (s, 2H, NH). ESI-MS (m/z, %): 




Synthesis of 10,20-dibromo-5,15-bis(4-methylphenyl)-21H,23H-Porphine 
(9.DiBr-MePor)63 
 
A CHCl3 solution (500 ml) of 
5,15-bis(4-methylphenyl)-21H,23H-Porphine (1.00 g, 2.04 mmol) was added 
pyridine (1 ml) and N-bromobutanimide (0.73 g, 4.08 mmol) at 0℃. After 
stirring at the same temperature for 1 hour, the solution was concentrated in 
vacuo. Then the product was purified by column chromatography in silica get 
(hexane/DCM 6:1) to yield a purple solid. Rf = 0.38. Yield: 0.60 g, 45.6 %. 1H 
NMR (500MHz, CDCl3) δ: 9.61 (d, 4H, pyrrole), 8.86 (d, 4H, pyrrole), 8.04 (d, 
4H, phenyl), 7.58 (d, 4H, phenyl), 2.72 (s, 6H, methyl), -2.73 (s, 2H, NH). 





2.2.3 Synthesis of the metal complexes 
The doping of the porphyrin with manganese, cobalt and zinc metal ions 
follows a similar procedure: 
Synthesis of 5,15-bis(4-methylphenyl)-21H,23H-Porphine manganese (Ⅲ) 
chloride (2.Mn-MePor)67 
 
5,15-bis(4-methylphenyl)-21H,23H-Porphine (0.50 g, 1.02 mmol) and 
MnCl2· 4H2O (20.09 g, 10.20 mmol) were dissolved in DMF (50 ml) and 
stirred at 110℃ for 3 hours. The solvent was vacuumed off and the product 
was re-dissolved in CH2Cl2 (100 ml) and washed with deionized water (100 
ml) 5 times. The organic phase was dried by Na2SO4 and vacuumed dry to 
yield the desired product as a dark green solid. Yield: 0.38 g, 62.8 %. ESI-MS 




Synthesis of 5,15-bis(4-methylphenyl)-21H,23H-Porphine cobalt (Ⅲ ) 
chloride (3.Co-MePor) 67 
 
5,15-bis(4-methylphenyl)-21H,23H-Porphine (0.50 g, 1.02 mmol) and 
CoCl2·6H2O (2.41 g, 10.20 mmol) were dissolved in DMF (50 ml) and stirred 
at 110℃ for 3 hours. The solvent was vacuumed off and the product was 
re-dissolved in CH2Cl2 (100 ml) and washed with deionized water (100 ml) 5 
times. The organic phase was dried by Na2SO4 and vacuumed dry to yield the 
desired product as a dark green solid. Yield: 0.42 g, 69.1 %. ESI-MS (m/z, %): 




Synthesis of 5,15-bis(4-ethylphenyl)-21H,23H-Porphine zinc (II) chloride 
(8.Zn-MePor) 67 
 
5,15-bis(4-methylphenyl)-21H,23H-Porphine (0.50 g, 1.02 mmol) and 
ZnCl2 (1.39 g, 10.20 mmol) were dissolved in DMF (50 ml) and stirred at 110℃ 
for 3 hours. The solvent was vacuumed off and the product was re-dissolved in 
CH2Cl2 (100 ml) and washed with deionized water (100 ml) 5 times. The 
organic phase was dried by Na2SO4 and vacuumed dry to yield the desired 
product as a dark purple solid. Yield: 0.32 g, 55.8 %. ESI-MS (m/z, %): 




Synthesis of 5,15-bis(phenyl)-21H,23H-Porphine manganese (Ⅲ) acetic 
(6.Mn-Por)68 
 
5,15-bis(phenyl)-21H,23H-Porphine (0.50 g, 1.08 mmol) and 
Mn(OAc)2·4H2O (2.65 g, 10.80 mmol) were dissolved in CHCl3 (100 ml) and 
methanol (100 ml) mixed solvent and stirred at 60℃ for 3 hours. The solvent 
was vacuumed off and the product re-dissolved in CH2Cl2 (100 ml) and 
washed with deionized water (100 ml) 5 times. The organic phase was dried 
by Na2SO4 and vacuumed dry to yield the desired product as a dark purple 




Synthesis of 5,15-bis(phenyl)-21H,23H-Porphine cobalt ( Ⅲ ) acetic 
(7.Co-Por) 68 
 
5,15-bis(phenyl)-21H,23H-Porphine (0.50 g, 1.08 mmol) and 
Co(OAc)2·4H2O (2.69 g, 10.80 mmol) were dissolved in CHCl3 (100 ml) and 
methanol (100 ml) mixed solvent and stirred at 60℃ for 3 hours. The solvent 
was vacuumed off and the product was re-dissolved in CH2Cl2 (100 ml) and 
washed with deionized water (100 ml) 5 times. The organic phase was dried 
by Na2SO4 and vacuumed dry to yield the desired product as a dark purple 




Synthesis of 5,15-bis(4-ethylphenyl)-21H,23H-Porphine manganese (Ⅲ) 
acetic (15.Mn-EtPor) 68 
 
5,15-bis(4-ethylphenyl)-21H,23H-Porphine (0.50 g, 0.96 mmol) and 
Mn(OAc)2·4H2O (2.35 g, 9.60 mmol) were dissolved in CHCl3 (100 ml) and 
methanol (100 ml) mixed solvent and stirred at 60℃ for 3 hours. The solvent 
was vacuumed off and the product was re-dissolved in CH2Cl2 (100 ml) and 
washed with DI water (100 ml) 5 times. The organic phase was dried by 
Na2SO4 and vacuumed dry to yield the desired product as a dark green solid. 




Synthesis of 5,15-bis(4-ethylphenyl)-21H,23H-Porphine cobalt (Ⅲ) acetic 
(16.Co-EtPor) 68 
 
5,15-bis(4-ethylphenyl)-21H,23H-Porphine (0.50 g, 0.96 mmol) and 
Co(OAc)2·4H2O (2.39 g, 9.60 mmol) were dissolved in CHCl3 (100 ml) and 
methanol (100 ml) mixed solvent and stirred at 60℃ for 3 hours. The solvent 
was vacuumed off and the product was re-dissolved in CH2Cl2 (100 ml) and 
washed with deionized water (100 ml) 5 times. The organic phase was dried 
by Na2SO4 and vacuumed dry to yield the desired product as a dark purple 




Synthesis of 10-bromo-5,15-bis(4-methylphenyl)-21H,23H-Porphine 
manganese (Ⅲ) acetic (13.Mn-MonoBr-MePor)63 
 
10-bromo-5,15-bis(4-methylphenyl)-21H,23H-Porphine (0.50 g, 0.87 
mmol) and Mn(OAc)2·4H2O (2.13 g, 8.70 mmol) were dissolved in CHCl3 
(100 ml) and methanol (100 ml) mixed solvent and stirred at 60℃ for 3 hours. 
The solvent was vacuumed off and the product was re-dissolved in CH2Cl2 
(100 ml) and washed with deionized water (100 ml) 5 times. The organic 
phase was dried by Na2SO4 and vacuumed dry to yield the desired product as a 





Synthesis of 10,20-dibromo-5,15-bis(4-methylphenyl)-21H,23H-Porphine 
manganese (Ⅲ) acetic (10.Mn-DiBr-MePor) 63 
 
10,20-dibromo-5,15-bis(4-methylphenyl)-21H,23H-Porphine (0.50 g, 
0.77 mmol) and Mn(OAc)2·4H2O (1.88 g, 7.70 mmol) were dissolved in 
CHCl3 (100 ml) and methanol (100 ml) mixed solvent and stirred at 60℃ for 
3 hours. The solvent was vacuumed off and the product was re-dissolved in 
CH2Cl2 (100 ml) and washed with deionized water (100 ml) 5 times. The 
organic phase was dried by Na2SO4 and vacuumed dry to yield the desired 
product as a dark green solid. Yield: 0.33 g, 56.3 %. ESI-MS (m/z, %): 





Synthesis of 10,20-dibromo-5,15-bis(4-methylphenyl)-21H,23H-Porphine 
cobalt (Ⅲ) acetic (11.Co-DiBr-MePor) 63 
 
10,20-dibromo-5,15-bis(4-methylphenyl)-21H,23H-Porphine (0.50 g, 
0.77 mmol) and Co(OAc)2·4H2O (1.91 g, 7.70 mmol) were dissolved in 
CHCl3 (100 ml) and methanol (100 ml) mixed solvent and stirred at 60℃ for 
3 hours. The solvent was vacuumed off and the product was re-dissolved in 
CH2Cl2 (100 ml) and washed with deionized water (100 ml) 5 times. The 
organic phase was dried by Na2SO4 and vacuumed dry to yield the desired 
product as a dark purple solid. Yield: 0.52 g, 88.2 %. ESI-MS (m/z, %): 
[M-OAc]+ (705.1, 100). 
 
2.3 Photo-absorption spectra 
2.3.1 General theory of UV-Vis characterization of porphyrins 
Porphyrin has specific absorption in UV-Vis range due to its rigid 
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macrocyclic conjugate plane. Based on this extraordinary feature, UV-Vis 
spectra can give us useful spectroscopic information on the successful 
synthesis of the porphyrin macrocycle as well as evidence of metal 
coordination into the porphyrin cavity.  
a). Characterization of the formation of porphyrins: The presence of the 
signature singular Soret and 4 Q peaks suggest the presence of porphyrin 
structure in the solution.19 
b). Characterization of the insertion of metal atom: Compared with 
porphyrins, the Q band of metal porphyrins has less peaks and the Soret is 
shifted. This shift is attributed to the coordination bonds.69 When the metal ion 
is inserted into the cavity, the metal ion will interact with the lone pair 
electrons of N atom to form σ donating bond, which will lower the electron 
density of porphyrins. At the same time, the d electrons of metal ion will 
overlap the empty orbit of the porphyrins (π back donating bond). If the σ 
donating bond gives more affinities on the density of electron cloud than π 
back donating bond, the density of electron cloud of porphyrin will decrease. 
Then the electron transition needs more energy, which will lead to blue-shift, 
whereas in the case of the absorption peak, a red-shift will be observed. 
 
2.3.2 UV-Vis spectrum of porphyrins 
The photophysical properties of the synthesized porphyrins and metal 
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complexes are studied in this sub-chapter. All the UV-Vis spectrum of 
porphyrins are shown in the appendix. The absorption spectra of the free base 
and metal doped porphyrins were obtained using CH2Cl2 as the solvent with 
same concentrations (4.0 μM). (Appendix Figure 1-6) Data in Table 2.1 
shows that all the 4 free base porphyrins and 2 bromine substituted porphyrins 
match the characterization of the formation of porphyrins. (Chapter 2.3.1) A 
comparison among the free base porphyrins at a fixed concentration of 4.0 μM 
in CH2Cl2 indicates that 4 kinds of free base porphyrins have almost same 
UV-Vis absorption peaks, which means that electron withdrawing or electron 
donating group (-Cl, -H, -CH3, -CH2CH3) in the para-5,15-phenyl positions 
don’t influence the UV-Vis properties of porphyrins. However, the change of 
functional groups in the para-10,20 positions make the UV-Vis spectra 
red-shifted. 10,20-dibromo-5,15-bis(4-methylphenyl)-21H,23H-Porphine 
(9.DiBr-MePor) is the most red-shifted one. The decrease in photon energy 
absorption was followed by 10-bromo-5,15-bis(4-methylphenyl)-21H,23H- 
Porphine (12.MonoBr-MePor). The auxochrome theory may be responsible 
for the red-shift. The anxochrome (-Br) does not have absorption in visible 
light range, but when it is connected with chromophoric groups, it makes p-π 
absorption peaks of chromophoric groups red-shifted.70 The p-π interaction 
between the lone pair electrons of anxochrome and the chromophoric groups 




Upon doping of metals into the cavity of the free base porphyrins 
(including the single bromine substituted porphyrin, excluding double 
bromines substituted prophyrins), the UV-Vis absorption of the doped 
porphyrins underwent radical changes. (Appendix Figure 1, Figure 3, Figure 
5 and Figure 6) The Soret bands were generally split into 2 Soret bands while 
the 4 Q bands were observed to merge into 2 or 3 Q bands (Chapter 2.3.1). 
(Table 2.2) The peak split is expected when considering Gouterman’s theory 
regarding the prophryin absorption spectrum in Chapter 1.2. The multiple 
Soret bands could be explained from the interaction of the metal orbitals and 
the porphyrin π/π* orbitals. When the prophyrin (π) → metal (dπ) 
charge-transfer transitions and the prophyrin (π→π*) transitions occur at 
equivalent energies, two Soret bands are observed as a sequence.71 
For 9.DiBr-MePor, when cobalt atom was inserted into the cavity, the 
peak 302 nm has disappeared and the Q band peak has merged into one peak. 
However, when manganese atom was inserted into the cavity only the peak 
302 nm has disappeared but the Q band peak has no obvious change which is 
due to multi-transition in energy level involving the presence of Br, main 




Table 2.1 UV-Vis absorption spectra data of porphyrins. 
Sample 
Peak/nm 
Q band Soret 
1.MePor 639 585 546 512 416 308 
4.ClPor 638 584 544 510 416 308 
5.Por 638 583 544 510 415 309 
9.DiBr-MePor 667 610 565 530 431 302 
12.MonoBr-MePor 653 597 557 521 431 312 
14.EtPor 639 585 546 512 416 314 
*Red data refers to the strongest absorption peaks. 
Table 2.2 UV-Vis absorption spectra data of metalloporphyrins 
Sample 
Peak/nm 
Q band Soret 
2.Mn-MePor 608, 577 480, 379 
3.Co-MePor 526 409 
6.Mn-Por 540, 511 414, 304 
7.Co-Por 525 408, 307 
8.Zn-MePor 545 417, 308 
10.Mn-DiBr-MePor 667, 609, 566, 530, 492 431 
11.Co-DiBr-MePor 542 425, 262 
13.Mn-MonoBr-MePor 619, 592, 522 481, 425, 384 
15.Mn-EtPor 575, 512, 474, 416, 379 
16.Co-EtPor 526 409, 307, 273 




Chapter 3 Bioassay  
 
3.1 Background information on bioassay 
Some support details are shown in Chapter 3.1 to provide background 
knowledge to help us demonstrate the bioassay results. 
 
3.1.1 Basic introduction to bacteria types 
3.1.1.1 Gram staining method 
Gram staining method is a highly reliable way to differentiate bacterial 
species, namely into two large groups (gram-positive and gram-negative) as 
defined by Danish scientist Hans Christian Gram.72 It differentiates bacteria 
based on the physical and chemical properties of their cell walls by detecting 
if they have peptidoglycan, which is present in a thick layer in gram-positive 
bacteria. Gram-positive bacteria have a thick mesh-like cell wall made of 
peptidoglycan (50–90% of cell envelope), and are easily stained purple by 
crystal violet, whereas gram-negative bacteria only have a thinner layer (10% 
of cell envelope), so are insusceptible to retain the purple stain, but rather they 
are counter-stained pink by the dye safranin. 
In a Gram stain test, bacteria are stained by alkaline crystal violet dye, 
after iodine mordant before being decolorized with alcohol. Gram-positive 
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bacteria retain the crystal violet dye and for easy observation, a counterstain 
(commonly safranin or fuchsine) will be added after decoloration providing all 
gram-negative bacteria a red or pink color for easy visual identification.73 
3.1.1.2 Gram-positive bacteria  
Gram-positive bacteria, a class of bacteria that take up the crystal violet 
stain used in the Gram staining method, have a single membrane surrounded 
by a thick peptidoglycan. The thick peptidoglycan layer in the cell wall that 
encases their cell membrane retains the stain, making definitive identification 
possible. As shown in the Figure 3.1, Gram-positive bacteria have a 15–80 nm 
thick cell wall that contains the following 5 main characteristics: a) 
cytoplasmic lipid membrane, b) up to 100 interconnecting layers of 
peptidoglycan, c) teichoic acid and lipoid form lipoteichoic acids that serve as 
chelating agents, d) the cross-linked peptidoglycan chains forming rigid cell 
walls with a bacterial enzyme named DD-transpeptidase, e) and ingrained 
proteins in the peptidoglycan layers.74 
 




3.1.1.3 Gram-negative bacteria  
In gram staining experiment, alcohol used in the decolorization process 
degrades the outer membrane of gram-negative cells, which makes the cell 
wall more porous and incapable of retaining the crystal violet stain. Thus, 
gram-negative bacteria cannot retain the violet stain after the decolorization 
step. However, their thin peptidoglycan layer is sandwiched between a 
bacterial outer membrane and an inner cell membrane, causing them to take up 
the counterstain (safranin or fuchsine) to appear red or pink. 
Gram-negative bacteria cell wall consists of a thin, inner wall composed 
of 2–3 layers of peptidoglycan (2–3 nm thick), a periplasmic space and an 
outer lipid bilayer (7 nm). The outer membrane contains phospholipids, 
lipoproteins, lipopolysaccharides (LPS) and proteins like porins. The space 
between the peptidoglycan layer and the inner cell membrane is named the 
periplasmic space. Some of them contain Braun's lipoprotein, which serves as 
a link between the outer membrane and the peptidoglycan chain by covalent 
bonds. And most bacterial phyla are gram-negative, including the spirochaetes, 
cyanobacteria, and green sulfur bacteria, as well as Escherichia coli and 













Figure 3.2 Schematic representations of the arrangement of the cell walls of 
gram-negative bacteria. 
 
3.1.1.4 Importance of differentiating between gram positive and gram 
negative bacteria  
One of the unique characteristics of gram-negative bacteria is the 
structure of the outer membrane. The outer membrane consists of a complex 
lipopolysaccharide whose lipid portion is toxic. Once the lipopolysaccharide 
enters the circulatory system, it may cause the sufferer to develop immune 
responsive symptoms such as high temperature, high respiration rate and low 
blood pressure. Such symptoms may lead to endotoxic shock, which can be 
fatal if left untreated.  
In terms of medical treatment, most gram-positive bacteria (excluding 
mycobacterium tuberculosis) is sensitive to penicillin, while gram-negative 
bacteria (excluding epidemic Diplococcus meningitidis and Neisseria 
gonorrhea) are not responsive to penicillin. This is because the outer 
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membrane of gram-negative bacteria protects the bacteria from several 
antibiotics (including lysozyme and penicillin) that would normally damage 
either the inner membrane or the peptidoglycan. Fortunately effective 
medicinal treatments such as lysozyme with EDTA, ampicillin, 
chloramphenicol, streptomycin and nalidixic acid have been developed to 
destroy the protective outer membrane of some pathogenic gram-negative 
organisms. Thus, it is of medical significance to distinguish the bacteria so as 
to identify the right choice of antibiotics for treatment.76 
 
3.1.2 Mechanism of some typical antibacterial compounds 
Before we discuss the bioassay results of the synthesized porphyrins and 
metalloporphyrins, some typical effective bactericidal substances and their 
methods of treatment are shown below to give more background information 
of bioassay in order to understand the mechanism of drug induced bacteria 
apoptosis. 
 
3.1.2.1 Bacteria inhibition by photodynamic therapy 
Photodynamic therapy towards bacteria is based on the concept that the 
certain photosensitizers (PS) accumulated in or at the cytoplasmic membrane 
can induce an irreversible damage in bacteria as a result of singlet O2 
generation 76 It should be noted that there is a clear difference in susceptibility 
51 
 
of photodynamic therapy between gram-positive and gram-negative bacteria.77 
In general, anionic and neutral photosensitizers were found to bind tightly with 
gram-positive bacteria, thereby inducing growth inhibition by PDT.  
In the case of gram-negative bacteria, despite the binding of PS to the 
outer membrane of gram-negative bacteria, cell fail to initialize.78, 79 Only 
when non-peptide polymyxin or Tris-EDTA (membrane disorganizing 
substances) is part of the porphyrin structure,  inhibition of the growth of E. 
coli (gram-negative bacteria) was observed. There are certainly clear 
differences to the medicinal approach taken with respect to the treatment of 
gram-positive and gram-negative bacteria (Figure 3.1 and Figure 3.2).  
 
3.1.2.2 Bacteria inhibition by administration of antibiotics 
Antibiotics are a class of secondary metabolites having anti-pathogen 
properties produced by microorganisms (including bacteria, fungi, 
actinomycetes) or higher plants and animals in the course of life. The first 
antibiotic called penicillin was discovered by Alexander Fleming in 1928. 
With advances in medicinal chemistry, most modern antibiotics are 
semisynthetic modifications of various natural compounds.80 For example, the 
β-lactam antibiotics (penicillins, cephalosporins, carbapenems), 
aminoglycosides (streptomycin, gentamicin, kanamycin), Amphenicols 
(chloramphenicol, thiamphenicol), macrolides (erythromycin, albomycin, 
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azithromycin), polypeptide antibiotics (vancomycin, norvancomycin, 
teicoplanin) and many others.  
Penicillin81 
During the growth of bacteria, their cell walls are constantly been 
building and breaking down. β-Lactam antibiotics can inhibit the formation of 
peptidoglycan cross-linked in the bacterial cell wall. This is because that 
four-membered β-lactam ring of penicillin bind to the enzyme 
DD-transpeptidase that catalyze the formation of these cross-links. Without 
formation of a peptidoglycan cross-linked cell wall bacteria rapidly die. 
(Figure 3.3) 
 
Figure 3.3 Core structure of penicillin and its mechanism of toxicity 
After treatment with penicillin, gram-positive bacteria loses cell walls 
integrity but penicillin has no effect on gram-negative bacteria. Penicillin is 
largely safe for human usage as human cells have different cell membrane 
receptors and structure as compared to bacteria. The outbreak of drug 
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resistance bacteria is largely due to over-administration of penicillin. This has 
resulted in less effective treatment, therefore requiring greater drug dosage as 
well as a pressing need for new type of antibiotics. 82  
Streptomycin 
Streptomycin is the second antibiotic found by human and the first 
effective drug for the treatment of tuberculosis. Streptomycin is an 
aminoglycosides drug that can penetrate the cell wall and cell membrane. It 
binds to the small 16S rRNA of the 30S subunit of the bacterial ribosome to 
interfere with the binding of formyl-methionyl-tRNA to the 30S subunit.83 
This leads to the faulty RNA transcription that inhibits synthesis of essential 
proteins necessary for development of microbial cells. Human ribosomes are 
structurally different from those in microbial cells, thus that mechanism is not 
effective in human cells. 
 
Figure 3.4 Structure of (a) Streptomycin and (b) Chloramphenicol 
Streptomycin is a useful broad-spectrum antibiotic because it inhibits 
both gram-positive and gram-negative bacteria. 84 But it is ineffective in the 
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treatment of tuberculous meningitis because of its poor blood-brain barrier 
penetration. Due to its degradation in kidney, the nephrotoxicity is quite 
significant.85 
Chloramphenicol  
Chloramphenicol is a typical broad-spectrum antibiotic that is effective 
against a wide variety of gram-positive and gram-negative bacteria, including 
most anaerobic organisms by inhibiting protein synthesis.86 Firstly, 
Chloramphenicol binds to A2451 and A2452 residues in the 23S rRNA of the 
50S ribosomal subunit so that the formation of peptide bond is prevented. 
Then the activity of the peptidyl transferase of targeted ribosome is inhibited, 
which finally prevents the elongation of protein chain.87  
In developing countries, chloramphenicol is widely used because of its 
low price. But it no longer belongs to the first choice of drug for infection 
treatment in developed countries due to resistance and safety concerns. But 
chloramphenicol is still the first-choice for the treatment of staphylococcal 
brain abscesses because of its excellent blood-brain barrier penetration. Except 
for some common side effects (fever, rashes, headache), the most serious one 
is bone marrow toxicity that may cause 2 results: one is bone marrow 
suppression, which is usually reversible; the other one is aplastic anemia that 





Vancomycin is a class of glycopeptide antibiotic that is effective mostly 
against gram-positive bacteria.89 Vancomycin binds to the terminal 
D-alanyl-D-alaine moieties of the N-acetylmuramic acid (NAM)/ 
N-acetylglucosamine (NAG)-peptides to destroy the five-point interaction 
(Figure 3.5), which prevents the synthesis of long polymers NAM and NAG 
that compose the backbone strands of cell wall of the bacteria. Then the 
cross-links of backbone polymers can’t form so that the cell wall is incomplete 
to resist the vancomycin. 
Vancomycin is the first-line drug for treatment of endocarditis, 
bloodstream infections and bone infections caused by methicillin-resistant S. 
aureus or caused by gram-positive bacteria in patients who are seriously 
allergic to β-lactam antimicrobials (penicillin).90 However, except for local 
pain, thrombophlebitis and anaphylaxis, vancomycin can induce 
platelet-reactive antibodies in the patients, leading to severe thrombocytopenia 




Figure 3.5 Vancomycin and its mechanism of action. 
 
3.1.3 Minimum inhibition concentration and drug-resistance 
Although scientists are continually developing new antibiotics, bacteria 
are now evolving new resistance to antibiotics due to overuse. The antibiotic 
treatment is also an evolutionary process where the bacteria that can survive 
high doses of antibiotics passed on such traits to their offsprings, thus 
conferring these abilities to future generations.92 This evolution of acquiring 
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antibacterial-resistance genes had been proved by Luria and Delbruck in 
1943.93 For example, antibiotics such as penicillin and erythromycin, which 
used to have a high efficacy against many bacterial species and strains, have 
become less effective, due to increased antibiotic resistance.94 The various 
range of MIC of some common antibiotics are shown in Table 3.1. 
Table 3.1 Examples of the minimum inhibition concentration of penicillin, 
streptomycin, Chloramphenicol and vancomycin.95 




Staphylococcus aureus positive 0.015 to 32 μg/ml 
Neisseria meningitidis negative 0.03 to 0.5 μg/ml 
Listeria monocytogenes positive 0.06 to 0.25 μg/ml 
Streptomycin 
Staphylococcus aureus positive 4 μg/ml 
Mycobacterium 
tuberculosis 
positive 1 to 2 μg/ml 
Chloramphenicol 
Staphylococcus aureus positive 0.06 to128 μg/ml 
Streptococcus 
pneumoniae 
positive 2 to 16 μg/ml 
Escherichia coli negative 0.015 to 10,000 μg/ml 
Vancomycin 
Staphylococcus aureus positive 0.25 to 4.0 μg/ml 
Staphylococcus aureus 
(methicillin resistant or 
MRSA) 
positive 1 to 138 μg/ml 
Staphylococcus 
epidermidis 
positive 0.12 to 6.25 μg/ml 
 
3.2 Bioassay 
3.2.1 Minimum inhibition concentration 
3.2.1.1 Experiment process  
The bacterial strains used in the MIC studies are S. aureus ATCC 29213 
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(Figure 3.8) and E. coli ATCC 10536 (Figure 3.7). The stock solution of the 
required porphyrin compound was dissolved in DMSO at 5 mg/ml. Serial 
two-fold dilutions of polymer solutions were prepared using Mueller Hinton 
Broth (MHB) in 96-well plate. The DMSO content is maintained lower than 3% 
so that it wouldn’t affect the bacteria properties. The bacterial suspension in 
MHB was added in each well at equal volume with polymer solution, resulting 
in approximately 5×105 CFU/ml. The concentration of serial polymer dilutions 
is 128, 64, 32, 16, 8, 4, 2, 1 and even down to 0.0039 µg/ml. (Figure 3.6) 
Polymer solution dissolved in MHB, the bacteria in MHB and MHB medium 
only were prepared as controls. The 96-well plate was incubated at 37°C for 
24 h. The absorbance at 600 nm of 96-well plate was read and the % growth of 
bacteria against the control compared. MIC is therefore defined as the lowest 
concentration of porphyrin compound that eliminates at least 99% of bacteria 
studied. 
The formula to calculate the % growth of bacteria is  
% growth = [ (porphyrin_bacteria_medium) - (porphyrin_medium) ] / 





Figure 3.6 Example of minimum inhibition concentration experiment. 
(15.Mn-EtPor) The number refers to the concentration of porphyrin and the 
unit of all the numbers is µg/ml. 
The tag names in above brackets are their corresponding absorbance 
values. If % growth is less than 1%, the corresponding concentration is MIC, 
which means 99% bacteria were killed by this lowest concentration. 
 




Figure 3.8 Schematic diagram of S.aureus97 
 
3.2.1.2 Results of MIC experiments 
From Figure 3.6, we found that wells containing 128, 64, 32, 16, 8, 4, 2, 
1, 0.5, 0.25, 0.125 µg/ml of metalloporphyrin solutions (15. Mn-MePor) are 
clear because the bacteria S.aureus were inhibited. Lower concentrations of 
metalloporphyrin solutions (15. Mn-MePor) at 0.0625, 0.03135, 0.0156, 
0.0078, 0.0039 µg/ml were turbid due to the growth of S.aureus. Cells 
A11&12 (medium_bacteria) acts as positive controls are expectedly turbid due 
to bacteria growth. Cells B11&12 (medium only) serves as the negative 
controls and registered clear homogenous solutions. Absorbance was 
calculated according to the formula in Chapter 3.2.1.1. The MIC value of 15. 
Mn-MePor is therefore derived as 0.125 μg/ml (Table 3.2). Generally, if the 
MIC value is bigger than 128 μg/ml, it means that dosage to inhibit the 
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bacteria is exceedingly high and therefore not an effective agent as an 
antibiotic.  
Tabulated in Table 3.2, all the free base porphyrins and metal salts were 
observed not to induce cell apoptosis to S.aureus and E.coli. However, when 
the free base porphyrins were coordinated with metals, they served as highly 
effective drugs to eliminate S.aureus and E.coli. The results suggest that the 
metal coordinated within the metalloporphyrins played a key role in 
antibacterial properties in our research.  
Sample 2.Mn-MePor-1 was synthesized with 1.MePor and MnCl2•
4H2O and sample 2.Mn-MePor-2 was synthesized with 1.MePor and 
Mn(OAc)2·4H2O. Because the manganese of metalloporphyrins has a valency 
of (III), the counter monoanion exist as Cl- or OAc-. The MIC test clearly 
indicates different counter monoanion do not have significant influence on the 
inhibition of both gram positive and negative bacteria. We propose that the 
monocation of metalloporphyrins is the active ingredient of bacterium 
apoptosis. This was further confirmed by the observation of why the neutral 
charged 8.Zn-MePor was not effective compared with other 
metalloporphyrins that possess monocation towards S.aureus and E.coli 
inhabitation. 
As discussed in Chapter 3.1.2.1, the negative charge at the outer surface 
of the bacterial cell76 (Figure 3.1 and Figure 3.2) could give rise to 
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electrostatic interaction between the positive charged metalloporphyrin 
monocation and the outer bacterial membrane surface. In order to validate this 
hypothesis, anionic surfactants was added to the solution containing the 
metalloporphyrin and bacteria. The result conclusively confirmed that in the 
presence of the anionic surfactant, antibacterial ability was drastically 
quenched. (Chapter 3.2.1.3) This observation provides support that the 
cationic metalloporphyrin acts as the main protagonist in elimination of both 
gram-positive and gram-negative bacterium.  
Based on the initial results, we can establish 2 types of mechanism, 
Firstly, the metalloporphyrins can directly bind with the membrane proteins. 
Secondly, the metalloporphyrins can penetrate into the membrane to interact 
with the organelle or DNA, RNA or proteins inside cells. It appears that the 
cell membrane of the bacteria plays a critical role in the effectiveness of the 
metalloporphyrins. In the case of E.coli which possesses a gram-negative type 
of cell membrane, the actual metal species within the metalloporphyrin is 
critical. This is because only metalloporphyrins containing manganese 
(2.Mn-MePor, 13.Mn-SingleBr-MePor, 15.Mn-EtPor) have proven 
effective in inhibiting E.coli to a certain degree, and it should also be noted 
that higher concentration of same metalloporphyrin is also needed for E.coli as 
compared to S.aureus. (Table 3.2) 
The MIC results also showed that the difference of substitution group in 
4-phenyl position clearly influence the antibacterial property. By enhancing 
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the electron donating substitution group in the 4-phenyl position, the 
antibacterial property of manganese doped porphyrins became more prominent 
and effective, however it should be noted that the cobalt doped porphyrins did 
not register any significant measurable bacterial inhibition tendency.  




1.MePor >128 >128 
2.Mn-MePor-1 1 16 
2.Mn-MePor-2 1 16 
3.Co-MePor 4 >128 
4.ClPor >128 >128 
5.Por >128 >128 
6.Mn-Por 4 >128 
7.Co-Por 32 >128 
8.Zn-MePor >128 >128 
9.DiBr-MePor >128 >128 
10.Mn-DiBr-MePor 1 >128 
11.Co-DiBr-MePor 64 >128 
12.SingleBr-MePor >128 >128 
13.Mn-SingleBr-MePor 0.25 8 
14.EtPor >128 >128 
15.Mn-EtPor 0.125 32 
16.Co-ErPor 128 >128 
Mn(OAc)2 >128 >128 
Co(OAc)2 >128 >128 
The addition of Br in 10, 20 position in porphyrin macrocycle was shown 
to suppress antibacterial inhibition for both manganese and cobalt porphyrins 
as compared to porphyrins without any Br atoms in the 10, 20 position. 
Contrarily, a single Br atom introduction in the 10 position of the porphyrin 
macrocycle was observed to enhance the metalloporphyrin’s antibacterial 
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capability as compared to a double Br atom substitution in the 10, 20 
porphyrin positions. Thus, these observations gave an indication on the 
necessary further modification of porphyrin for further improvement in terms 
of bacteria inhibition. Clearly, shape selectivity is a critical factor in the 
bacteria inhibition mechanism.  
A short summary concludes that, the antibacterial property arise from the 
overall effect of porphyrin macrocycle, metal center, functional groups, and 
substituted groups.  
In our group, many other compounds have been tested by MIC 
experiments, but only the use of metalloporphyrin resulted in a pervasive 
sulfur-like odor upon completion of the 24 h MIC experiment. It is possible 
that some volatile sulfur compounds were produced through the 
decomposition of proteins98, as induced by metalloporphyins in the studies. As 
manganese and cobalt porphyrins are capable of multiple valence state, the 
redox reaction between the metalloporphyrins and protein of bacteria cannot 
be ruled out. Another possible hypothesis is those manganese and cobalt 
centres of the metalloporphyrins are Lewis acids99, 100 which can coordinate to 
the sulphur present in bacteria cell walls, thereby inducing a detrimental effect 
on the survivability of the targeted bacterium. We are now currently pursuing 
the identification of these volatile Sulphur-like compounds so as to better 
understand the mechanism of bacterium inhibition by the use of the 
metalloporphyrins.   
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3.2.1.3 Antibacterial property of metalloporphyrins in the presence of 
anionic surfactants 
Objective 
We are testing the minimum inhibition concentration (MIC) of E. coli 
bacteria with treatment of metalloporphyrins in the presence of anionic 
surfactants to evaluate their antibacterial property in the presence of different 
levels and types of anionic surfactants. This is to evaluate if charge of the 
metalloporphyrins plays a part in bacteria inhibition.  
Methods 
The bacterial strains used in these studies were E. coli ATCC 10536. The 
stock solution of metalloporphyrin was dissolved in DMSO at 5 mg/ml. The 
surfactants were dissolved in Mueller Hinton Broth (MHB) at the two-fold 
recommended concentration. Serial two-fold dilutions of metalloporphyrin 
solutions were prepared in surfactant added MHB in 96-well plate. The 
bacterial suspension in MHB was added in each well at equal volume with 
metalloporphyrin solution, resulting in approximately 5×105 CFU/ml. The 
concentration of serial metalloporphyrin dilutions is 128, 64, 32, 16, 8, 4, 2 
and 1 µg/ml. Metalloorphyrin solution dissolved in MHB, the bacteria in 
MHB, the bacteria in surfactant added MHB and MHB medium only were 
prepared as controls. The 96-well plate was incubated at 37°C for 20-24 h. The 
absorbance at 600 nm of 96-well plate was read and calculated the % growth 
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of bacteria against the controls. MIC was the concentration at which 99% of 
bacteria were eliminated. 
Results 
To test the MIC of metalloporphyrin against Gram-negative E. coli, it 
was found that the MICs of 2.Mn-MePor and 13.Mn-MonoBr-MePor are 16 
and 8 µg/ml without surfactants, respectively. However, when the surfactants 
were added in the solution, the MIC of porphyrins increased to be larger than 
128 µg/ml; thereby indicating suppression of bacteria inhibition properties by 
2.Mn-MePor and 13.Mn-MonoBr-MePor in the presence of these anionic 
surfactants. This could be due to the cationic Mn3+ inside the metalloporphyrin 
being effectively neutralized by the anionic surfactant. (Table 3.3) It should be 
noted that the surfactants themselves don’t have any toxicity to E. coli cells. 
Supporting information 
Surfactant 1: Total surfactant is 9.5% anionic surfactant (blend of sodium ethyl 
benzene sulfonate and sodium ethyl ethoxy sulfate). It should be diluted 250X 
for testing, i.e. 0.4% surfactant solution. 
Surfactant 2: Total surfactant is 7.5%, with 5% anionic surfactant (ethyl 
benzene sulfonate) and 2.5% non-ionic surfactant. It should be diluted 500X 
for testing, i.e. 0.2% surfactant solution. 
Surfactant 3: Total surfactant is 25% with 15% anionic surfactant (sodium 
ethyl ethoxy sulfate) and 10% of non-ionic surfactant. It should be diluted 
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100X for testing, i.e. 1% surfactant solution. 
 
Figure 3.9 (a) sodium ethyl benzene sulfonate; (b) sodium ethyl ethoxy sulfate 
Table 3.3 Anti-bacterial activity of porphyrin against E. coli in the presence of 
anionic surfactant 
Sample Name Surfactant MIC of E.coli (µg/ml) 
2.Mn-MePor No 16 
2.Mn-MePor Surfactant 1 >128 
2.Mn-MePor Surfactant 2 >128 
2.Mn-MePor Surfactant 3 >128 
13.Mn-MonoBr-MePor No 8 
13.Mn-MonoBr-MePor Surfactant 1 >128 
13.Mn-MonoBr-MePor Surfactant 2 >128 
13.Mn-MonoBr-MePor Surfactant 3 >128 
 
3.2.2 Hemolysis--Selectivity study 
We have shown in Chapter 3.2.1 that the synthesized metalloporphyrins 
are effective towards inhibition of both gram positive and negative bacteria. 
For practical healthcare applications, non-toxicity of metalloporphyrins 
towards mammalian cells is a major concern. A series of hemolysis tests of 
rabbit blood cells were designed to evaluate cytotoxicity in mammalian cells. 
MIC and bactericidal concentrations (2 × and 4 × MIC) were tested in the 
hemolysis test following Koh’s method.61 For every concentration, 3 parallel 
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experiments have been done in order to obtain a statistical evaluation. 
 
3.2.2.1 Experiment process 
The hemolytic activity of the evaluated compound of metalloporphyrin 
was determined by measuring the amount of hemoglobin released from rabbit 
erythrocytes. The measurement method was calculated from the calibrated 
absorbance spectrum of the cultivated solution. Fresh rabbit red blood cells 
(RBCs) were isolated from the blood of New Zealand white rabbits, in the 
Singapore National Eye Center, and the extraction procedure according to the 
standards of the Association for Research in Vision and Ophthalmology. The 
blood was centrifuged at 3000 rpm for 10 min and the top layer was removed. 
The rest of the blood (RBCs) was washed twice with sterile phosphate buffer 
solution (PBS) and diluted to 8% (v/v) stock solution in sterile PBS. 100µl of 
each effective metalloporphyrin solution (in PBS) was prepared in Eppendorf 
tube with concentration two times higher than the desired concentration. 100 
µl of red blood cell was added into each Eppendorf tube, thus final 
concentration of red blood cell is 4% (v/v) and the metalloporphyrin were also 
diluted into desired concentration. Triton X-100 (4% stock, final concentration 
in the tube is 2%) and red blood cell (final v/v of RBCs=4%) were mixed 
together as positive control. The negative control is a mixture of PBS and red 
blood cells (final v/v of RBCs=4%).61  
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All the Eppendorf tubes were incubated at 37˚C for 1 hour. (Figure 3.10) 
Then the tubes were centrifuged at 3000 rpm for 2 minutes. Finally 100µl 
supernatant of each Eppendorf tube was transferred into a well in the 96-well 
plates (Figure 3.11) to read the absorbance at 576 nm (10 flash). The 
hemolysis was calculated according to the formula below: 
%Hemolysis = ( [metalloporphyrins sample] - [Negative control] ) / 
( [Positive control] - [Negative control] ) * 100% 
 
Figure 3.10 Hemolysis (a) an overlook of parts of hemolysis samples 
(comment: 2-1 means sample (2.Mn-MePor)-1µg/ml) (b) a horizontal look of 
parts of hemolysis sample (c) rabbit blood (d) blood before incubation 
(opaque) (e) positive control: blood and Triton X-100 (transparent after 1 h 
incubation) (f) negative control: blood (opaque after 1 h incubation) (g) 
sample: metalloporphyrin and blood (opaque after 1 h incubation) (h) sample 
after centrifugation (after 1 h incubation) (i) negative control after 
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centrifugation (after 1 h incubation) (j) positive control after centrifugation 
(after 1 h incubation).  
 
3.2.2.2 Results of hemolysis 
As shown in Figure 3.10 (b) (c) (d), the red blood cells were opaque. 
After 1 hour incubation, the RBCs with metalloporphyrin and negative control 
were still opaque (Figure 3.10 (f) (g)), but the positive control became 
transparent (Figure 3.10 (e)) so that we can see the iron bar behind the 
Eppendorf tube. After centrifugation, the RBCs with metalloporphyrin and 
negative control became distinguishable in each Eppendorf tube (Top layer is 
supernatant, and the bottom layer is live RBCs). The positive control remains 
as a red and transparent solution entirely, due to destruction of the RBCs by 
the poison Triton X-100, thereby leading to the release of hemoglobin from 
the rabbit’s erythrocytes.  
100 µl of the supernatant from each Eppendorf tube was transferred into 
a well in the 96-well plates. From Figure 3.11, all the supernatant of 
metalloporphyrins and negative control sample were almost colorless, which 
was a sharp contrast compared with the red supernatant of the positive control 
sample. The absorbance values tabulated in Table 3.4 gave measurable 
insights corresponding to the observable difference in color. The absorbance of 
metalloporphyrins is almost similar to that of the negative control, which mean 
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that the metalloporphyrins synthesized in our research are clearly non- toxic to 
rabbit red blood cells. Although the absorbance of 
13.Mn-MonoBr-MePor-32µg/ml (6.66) and 15.Mn-EtPor-128µg/ml (3.12) 
appears slightly higher than other metalloporphyrins, but in consideration of 
their exceedingly high concentration (13.Mn-MonoBr-MePor-32µg/ml, 128 
× MIC (S. aureus); 15.Mn-EtPor-128µg/ml, 1024 × MIC (S. aureus)), this 
should not be a problem in actual treatment as only a minimal concentration is 
required for bacteria inhabitation. . 
 
Figure 3.11 96-well plates for absorbance test of hemolysis. (1-1) one part of 
samples; (1-2) samples in (1-1) with concentration on cover; (2-1) the other 








1 2 3 Average 
2.Mn-MePor-1µg/ml 0.0601 0.0582 0.0631 0.0605 -0.27  
2.Mn-MePor-2µg/ml 0.0593 0.0560 0.0632 0.0595 -0.32  
2.Mn-MePor-4µg/ml 0.0541 0.0593 0.0552 0.0562 -0.48  
2.Mn-MePor-16µg/ml 0.0600 0.0570 0.0657 0.0609 -0.25  
2.Mn-MePor-32µg/ml 0.0706 0.0668 0.0709 0.0694 0.16  
2.Mn-MePor-64µg/ml 0.1104 0.1039 0.1019 0.1054 1.88  
3.Co-MePor-4µg/ml 0.0732 0.0564 0.0806 0.0701 0.19  
3.Co-MePor-8µg/ml 0.0641 0.0658 0.0653 0.0651 -0.05  
3.Co-MePor-16µg/ml 0.0685 0.0633 0.0659 0.0659 -0.01  
6.Mn-Por-4µg/ml 0.0638 0.0621 0.0772 0.0677 0.07  
6.Mn-Por-8µg/ml 0.0638 0.0656 0.0679 0.0658 -0.02  
6.Mn-Por-16µg/ml 0.0658 0.0700 0.0637 0.0665 0.01  
7.Co-Por-32µg/ml 0.0565 0.0601 0.0591 0.0586 -0.37  
7.Co-Por-64µg/ml 0.0559 0.0638 0.0630 0.0609 -0.25  
7.Co-Por-128µg/ml 0.0647 0.0652 0.0700 0.0666 0.02  
10.Mn-DiBr-MePor-1µg/ml 0.0701 0.0652 0.0659 0.0671 0.04  
10.Mn-DiBr-MePor-2µg/ml 0.0703 0.0695 0.0693 0.0697 0.17  
10.Mn-DiBr-MePor-4µg/ml 0.0680 0.0670 0.0638 0.0663 0.00  
11.Co-DiBr-MePor-64µg/ml 0.0627 0.0757 0.0689 0.0691 0.14  
11.Co-DiBr-MePor-128µg/ml 0.0886 0.0833 0.0741 0.0820 0.76  
11.Co-DiBr-MePor-256µg/ml 0.0852 0.0761 0.0949 0.0854 0.92  
13.Mn-MonoBr-MePor-0.25µg/ml 0.0671 0.0623 0.0631 0.0642 -0.10  
13.Mn-MonoBr-MePor -0.5µg/ml 0.0791 0.0601 0.0722 0.0705 0.20  
13.Mn-MonoBr-MePor -1µg/ml 0.0875 0.0761 0.0708 0.0781 0.57  
13.Mn-MonoBr-MePor -8µg/ml 0.0795 0.0754 0.0911 0.0820 0.76  
13.Mn-MonoBr-MePor -16µg/ml 0.1007 0.1397 0.1288 0.1231 2.73  
13.Mn-MonoBr-MePor -32µg/ml 0.1914 0.2364 0.1876 0.2051 6.66  
15.Mn-EtPor-0.125µg/ml 0.0619 0.0601 0.0616 0.0612 -0.24  
15.Mn-EtPor -0.25µg/ml 0.0620 0.0586 0.0571 0.0592 -0.33  
15.Mn-EtPor -0.5µg/ml 0.0571 0.0590 0.0606 0.0589 -0.35  
15.Mn-EtPor -32µg/ml 0.0802 0.0746 0.0677 0.0742 0.38  
15.Mn-EtPor -64µg/ml 0.0964 0.0937 0.1006 0.0969 1.47  
15.Mn-EtPor -128µg/ml 0.1509 0.1188 0.1242 0.1313 3.12  
16.Co-EtPor-128µg/ml 0.0595 0.0624 0.0525 0.0581 -0.39  
16.Co-EtPor -256µg/ml 0.0569 0.0615 0.0652 0.0612 -0.24  
16.Co-EtPor -512µg/ml 0.0766 0.0748 0.0786 0.0767 0.50  
Positive control 2.0380 2.0237 2.3941 2.1519 
Negative control 0.0653 0.0625 0.0708 0.0662 
73 
 
3.2.3 MTT assay 
3.2.3.1 Mechanism of MTT assay 
The MTT assay is a colorimetric assay for assessing cell viability. 
NAD(P)H-dependent cellular oxidoreductase enzymes can reduce the 
tetrazolium dye MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide] into insoluble purple formazan, which reflects the number of viable 
cells. (Scheme 3.1) Thus the tetrazolium dye assays are used to measure 
cytotoxicity (loss of viable cells) or cytostatic activity of potential medicinal 
agents and toxic materials. It should be noted that MTT assays are usually 
done in the dark because the MTT reagent is sensitive to light. 62  
Scheme 3.1 Mechanism of MTT assay. 
 
3.2.3.2 Experiment process 
The cytotoxicity of the metalloporphyrins was evaluated using the MTT 
assay in CCD-112CoN human fibroblast cell lines. They were cultured in 
Dulbecco’s modified eagle medium (DMEM), supplemented with 10% fetal 
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bovine serum (FBS), 100 units/ml of penicillin and 100 μg/ml of streptomycin 
at 37 °C under 5% CO2, and 95% relative humidity atmosphere. The cells 
were seeded in a 96-well plate at a density of 5x104 cells/well and incubated in 
100 μl of DMEM/well for 24 h. The culture media were replaced with fresh 
culture media containing metalloporphyrin solutions at concentration of 1 × 
MIC, 2 × MIC and 4 × MIC, and the cells were incubated for 24 h. Then, 10 μl 
of sterile-filtered MTT stock solution in PBS (5 mg/ml) was added to each 
well, reaching a final MTT concentration of 0.5 mg/ml. After 4 h, the 
unreacted dye was removed by aspiration. The produced formazan crystals 
were dissolved in DMSO (100 μl/well). The absorbance was measured using a 
microplate reader (Infinite M200, Tecan) at wavelength of 570 nm. The cell 
viability (%) relative to control cells cultured in media without porphyrins was 
calculated from [A]test / [A]control × 100%, where [A]test and [A]control are 
the absorbance values of the wells (with the metalloporphyrins) and control 
wells (without the metalloporphyrins), respectively. For each sample, the final 
absorbance was the average of those measured from three wells in parallel. 
Figure 3.12 Parts 96-well plates for absorbance test of MTT assay. (Right is 
the left one with concentration on cover. C means control.) 
75 
 
Table 3.5 Concentration distribution of MTT assay. (MIC, 2 × MIC, 4 × MIC 
and 128μg/ml) 
Sample* 2 3 6 7 10 11 13 15 16 
MIC 
(μg/ml) 
S.aureus 1 4 4 32 1 64 0.25 0.125 128 
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*sample 2: 2.Mn-MePor; sample3: 3.Co-MePor; sample 6: 6.Mn-Por; sample7: 
7.Co-Por; sample10: 10.Mn-DiBr-MePor; sample11: 11.Co-DiBr-MePor; 
sample13: 13.Mn-MonoBr-MePor; sample15: 15.Mn-EtPor; sample16: 
16.Co-EtPor. 
 
3.2.3.3 Result of MTT assay 
The Table 3.6 showed that except for 11.Co-DiBr-MePor, the rest of 
metalloporphyrins have traces of cytotoxicity towards human fibroblast cell at 
exceedingly high concentrations of approximately 128 μg/ml. This however is 
not be a cause for concern as the MIC of most metalloporphyrins tested in our 
case is very low. So the cytotoxicity of real application concentration (MIC, 2 
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× MIC and 4 × MIC) should be meaningful concentration in this MTT assay. 
According to Figure 3.13, under MIC, 2 × MIC and 4 × MIC, 2.Mn-MePor, 
3.Co-MePor, 6.Mn-Por, 10.Mn-DiBr-MePor, 11.Co-DiBr-MePor and 
15.Mn-EtPor have no obvious influence on human fibroblast cells (Cell 
viability ≥ 80%). 13.Mn-MonoBr-MePor performed well under MIC, but 
when the concentration increased to 2 × MIC and 4 × MIC, the cytotoxicity 
became very acute. 7.Co-Por and 16.Co-EtPor are poisonous to human 
fibroblast cells under MIC, 2 × MIC and 4 × MIC. One important observation 
was the discovery that the MIC, 2 × MIC and 4 × MIC of 7.Co-Por and 
16.Co-EtPor are far higher than those of 2.Mn-MePor, 3.Co-MePor, 
6.Mn-Por, 10.Mn-DiBr-MePor and 15.Mn-EtPor, yet similar to that of 
11.Co-DiBr-MePor. This indicates a much higher concentration of cobalt 
doped porphyrins is required for bacteria inhibition. The absorbance values 
and cell viability were shown in Table 3.7, Table 3.8 and Table 3.9.  










2.Mn-MePor 0.5463 0.4741 0.4888 0.5031  37.67  2.86  
3.Co-MePor 0.3551 0.3944 0.3379 0.3625  27.14  2.17  
6.Mn-Por 0.2390 0.2406 0.2193 0.2330  17.44  0.89  
7.Co-Por 0.1669 0.1896 0.1437 0.1667  12.48  1.72  
10.Mn-DiBr-MePor 0.1874 0.1823 0.1648 0.1782  13.34  0.89  
11.Co-DiBr-MePor 1.1777 1.1699 1.2398 1.1958  89.54  2.87  
13.Mn-MonoBr-MePor 0.3288 0.2982 0.2731 0.3000  22.47  2.09  
15.Mn-EtPor 0.1566 0.1755 0.1617 0.1646  12.32  0.73  
16.Co-EtPor 0.2227 0.2473 0.2221 0.2307  17.27  1.08  





Figure 3.13 Cell viability comparison under MIC, 2 × MIC and 4 × MIC 
(S.aureus). 
When the data was arranged based on the change of cell viability with the 
increasing concentration in Figure 3.14, a conclusion could be drawn. 
Increasing the concentration of 2.Mn-MePor has no obvious detrimental 
influence on its cytotoxicity until a exceedingly high value of 128 μg/ml. 
Hence, 2.Mn-MePor has an excellent toxic-free concentration ranging from 1 
to 64 μg/ml. Due to its excellent low MIC and impressive cytotoxicity-free 
concentration range in mammalian cells from the hemolysis results, 
2.Mn-MePor may potentially be an promising next generation antibiotic.  
3.Co-MePor, 6.Mn-Por, 10.Mn-DiBr-MePor, 11.Co-DiBr-MePor and 
15.Mn-EtPor are also excellent in the concentration range of MIC, 2 × MIC 







































































































































































metalloporphyrins having obvious influence on the antibacterial property in 
Chapter 3.2.1.2. The cytotoxicity of metalloporphyrins now showed some 
connection with the difference of substitution groups under MIC, 2 × MIC and 
4 × MIC. There is no notable effect on the cytotoxicity of manganese 
porphyrins when increasing the electron donating capabilities of the 
substitution group in the 4-phenyl position; however the cytotoxicity of the 
cobalt porphyrins became significantly enhanced. The addition of Br in 10, 20 
position in porphyrin macrocycle didn’t change the toxicity of 
metalloporphyrin including manganese and cobalt porphyrins. However, if 
only one Br is introduced in meso-10 position in the metalloporphyrin 
macrocycle, the cytotoxicity was observed to enhance acutely upon increasing 
concentration.  
 

























0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 512
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 Table 3.7 Cell viability under MIC (S.aureus and E.coli). 
*sample 2: 2.Mn-MePor; sample3: 3.Co-MePor; sample 6: 6.Mn-Por; sample7: 
7.Co-Por; sample10: 10.Mn-DiBr-MePor; sample11: 11.Co-DiBr-MePor; 












2 1 1.0058 0.8707 1.0983 0.9916 74.25 8.57 
3 4 1.2980 1.2201 1.2952 1.2711 95.18 3.31 
6 4 1.1633 1.0840 1.1819 1.1431 85.59 3.89 
7 32 0.3585 0.4458 0.3380 0.3808 28.51 4.29 
10 1 1.3973 1.4670 1.4910 1.4518 108.70 3.64 
11 64 1.1461 1.1733 1.1933 1.1709 87.67 1.77 
13 0.25 1.1852 1.3302 1.1847 1.2334 92.35 6.28 
15 0.125 1.1088 1.2783 1.1937 1.1936 89.37 6.35 
16 128 0.2227 0.2473 0.2221 0.2307 17.27 1.08 
 
MIC 
(Ecoli)       
2 16 1.2639 1.3074 1.2088 1.2600 94.35 3.70 
13 8 0.1509 0.1458 0.1276 0.1414 10.59 0.92 
15 32 0.3847 0.3216 0.2180 0.3081 23.07 6.30 
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2 2 0.9891 1.0602 1.0249 1.0247 76.73  2.66  
3 8 1.5805 1.4324 1.5031 1.5053 112.71  5.55  
6 8 1.0049 0.9588 1.0316 0.9984 74.76  2.76  
7 64 0.1835 0.1406 0.1272 0.1504 11.26  2.20  
10 2 0.8075 0.7135 0.9349 0.8186 61.30  8.32  
11 128 1.1777 1.1699 1.2398 1.1958 89.54  2.87  
13 0.5 0.5156 0.4608 0.3206 0.4323 32.37  7.53  
15 0.25 1.1581 1.1166 1.2446 1.1731 87.84  4.89  
16 256 0.2760 0.4082 0.2961 0.3268 24.47  5.33  
 
2xMIC 
(Ecoli)       
2 32 1.2889 1.4088 1.2244 1.3074 97.89  7.01  
13 16 0.1344 0.1155 0.1305 0.1268 9.49  0.75  
15 64 0.1466 0.1328 0.1339 0.1378 10.32  0.57  
*sample 2: 2.Mn-MePor; sample3: 3.Co-MePor; sample 6: 6.Mn-Por; sample7: 
7.Co-Por; sample10: 10.Mn-DiBr-MePor; sample11: 11.Co-DiBr-MePor; 
















2 4 1.1827 1.0994 1.1392 1.1404 85.39  3.12  
3 16 1.2550 1.3856 1.2058 1.2821 96.00  6.96  
6 16 0.8257 1.0226 0.9193 0.9225 69.08  7.37  
7 128 0.1669 0.1896 0.1437 0.1667 12.48  1.72  
10 4 1.2608 1.4639 1.4487 1.3911 104.16  8.47  
11 256 1.0586 1.1852 1.2859 1.1766 88.10  8.53  
13 1 0.1587 0.2390 0.2116 0.2031 15.21  3.06  
15 0.5 1.4597 1.3521 1.3505 1.3874 103.89  4.69  
16 512 0.4963 0.3798 0.3703 0.4155 31.11  5.25  
 
4xMIC 
(Ecoli)       
2 64 0.9853 0.9600 0.8710 0.9388 70.29  4.50  
13 32 0.1281 0.1285 0.1433 0.1333 9.98  0.65  
15 128 0.1566 0.1755 0.1617 0.1646 12.32  0.73  
*sample 2: 2.Mn-MePor; sample3: 3.Co-MePor; sample 6: 6.Mn-Por; sample7: 
7.Co-Por; sample10: 10.Mn-DiBr-MePor; sample11: 11.Co-DiBr-MePor; 
sample13: 13.Mn-MonoBr-MePor; sample15: 15.Mn-EtPor; sample16: 
16.Co-EtPor. 
 
3.3 Summary  
In this chapter, the synthesized porphyrins were evaluated with MIC, 
hemolysis and MTT assay in order to determine the compounds efficacy 
towards bacteria inhibition as well as cytotoxicity towards mammalian and 
human fibroblast cells. It was found that only charged metalloporphyrins have 
the ability to induce bacteria (S. aureus and E. coli) apoptosis. An obvious 
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advantage in the use of manganese metalloporphyrin is also the lack of 
cytotoxicity towards mammalian cells as shown in the hemolysis and MTT 
assay.  
It is clear that increasing the electron donating substitution group in 
4-phenyl position imparts stronger antibacterial property for the manganese 
porphyrins, while maintaining their excellent low cytotoxicity properties 
towards mammalian and fibroblast cells. It is important to note that manganese 
metalloporphyrins do not have obvious toxicity to human fibroblast cells as 
compared to cobalt metalloporphyrins. Inhibition of gram-negative bacteria 
E.coli was also only observed with manganese metalloporphyrins. From our 
observations, manganese metalloporphyrins therefore weighs higher on our 
list of anti-bacteria compound tested.  
The addition of Br in 10, 20 position in porphyrin macrocycle was noted 
to weaken the antibacterial property of metalloporphyrin for both manganese 
and cobalt metalloporphyrins, although changes in the cytotoxicity influence 
was minimal. One interesting observation was in the nucleophilic substitution 
of a Br atom at the meso-10 position of the porphyrin macrocycle actually 
improves antibacterial property but resulted in a slight increment in 
cytotoxicity towards mammalian and human fibroblast cells. Future work will 
involve exploring the nucleophilic substitution of other heteroatoms in the 5, 
10-meso porphyrin macrocycle position.  
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In conclusion, 2.Mn-MePor can potentially serve as a promising 
antibiotic compound due to its excellent low MIC, cytotoxic-free range of 
concentration and hemolysis non-cytotoxicity. 3.Co-MePor, 6.Mn-Por, 
10.Mn-DiBr-MePor, 11.Co-DiBr-MePor and 15.Mn-EtPor are also 
excellent in the concentration range of MIC, 2 × MIC and 4 × MIC. Further 
exploration of novel metalloporphyrin structures and metal coordination will 
hopefully give rise to new generations of antibiotics compounds in the 
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Figure 1 (a) Absorption spectrum of 5,15-bis(4-methylphenyl)-21H,23H- 
Porphine (1.MePor), (b) Absorption spectrum of 5,15-bis(4-methylphenyl)- 
21H,23H-Porphine manganese (III) chloride (2.Mn-MePor), (c) Absorption 
spectrum of 5,15-bis(4-methylphenyl)-21H,23H-Porphine cobalt (III) chloride 
(3.Co-MePor), (d) Absorption spectrum of 5,15-bis(4-methylphenyl)- 
21H,23H-Porphine zinc (II) chloride (8.Zn-MePor). Pictures of the dissolved 










Figure 2 Absorption spectrum of 5,15-bis(4-chlorophenyl)-21H,23H- 
Porphine (4.ClPor). Picture of the dissolved porphyrin is taken of 









Figure 3 (a) Absorption spectrum of 5,15-bis(phenyl)-21H,23H-Porphine 
(5.Por), (b) Absorption spectrum of 5,15-bis(phenyl)-21H,23H-Porphine 
manganese (III) acetic (6.Mn-Por), (c) Absorption spectrum of 
5,15-bis(phenyl)-21H,23H-Porphine cobalt (III) acetic (7.Co-Por). Pictures of 









Figure 4 (a) Absorption spectrum of 10,20-dibromo-5,15-bis(4- 
methylphenyl)-21H,23H-Porphine (9.DiBr-MePor), (b) Absorption spectrum 
of 10,20-dibromo-5,15-bis(4-methylphenyl)-21H,23H-Porphine manganese 
(III) acetic (10.Mn-DiBr-MePor), (c) Absorption spectrum of 10,20-dibromo- 
5,15-bis(4-methylphenyl)-21H,23H-Porphine cobalt (III) acetic 
(11.Co-DiBr-MePor). Pictures of the dissolved porphyrins are taken of 









Figure 5 (a) Absorption spectrum of 10-bromo-5,15-bis(4-methylphenyl)- 
21H,23H-Porphine (12.MonoBr-MePor), (b) Absorption spectrum of 
10-bromo-5,15-bis(4-methylphenyl)-21H,23H-Porphine manganese ( Ⅲ ) 
acetic (13.Mn-MonoBr-MePor). Pictures of the dissolved porphyrins are 









Figure 6 (a) Absorption spectrum of 5,15-bis(4-ethylphenyl)-21H,23H- 
Porphine (14.EtPor), (b) Absorption spectrum of 5,15-bis(4-ethylphenyl)- 
21H,23H-Porphine manganese (Ⅲ) acetic (15.Mn-EtPor), (c) Absorption 
spectrum of 5,15-bis(4-ethyllphenyl)-21H,23H-Porphine cobalt (Ⅲ) acetic 
(16.Co-EtPor). Pictures of the dissolved porphyrins are taken of concentration 
4.0 μM in CH2Cl2. 
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